arginine has been researched along with Glycogen Storage Disease Type II in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, L; Lim, JA; Puertollano, R; Raben, N; Shirihai, OS; Trudeau, KM | 1 |
1 other study(ies) available for arginine and Glycogen Storage Disease Type II
| Article | Year |
|---|---|
Modulation of mTOR signaling as a strategy for the treatment of Pompe disease.
Topics: Animals; Arginine; Disease Models, Animal; Glycogen Storage Disease Type II; Mice; Mice, Knockout; Muscles; Signal Transduction; TOR Serine-Threonine Kinases; Treatment Outcome | 2017 |